|Articles|August 2, 2003
- Pharmaceutical Technology-08-02-2003
- Volume 27
- Issue 8
New FDA Initiatives Aim to Spur Innovation
Author(s)Jill Wechsler
Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.
Advertisement
Articles in this issue
about 23 years ago
BIO Updateabout 23 years ago
Designing Transfer Carts for Class 100 Conditionsabout 23 years ago
An Update on Osmotic Drug Deliveryabout 23 years ago
Interphex Serves as a Showcase for New Materials and Machinesabout 23 years ago
August 2003about 23 years ago
In the Spotlight August 2003Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Danish Biotechs Attracting Investor Attention
3
Three Formats, One Platform: Halo's New Sterile Fill-Finish Line
4
CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda
5